COVID-19 Prevention through N-Acetylcysteine (NAC) Supplements for Oxidative Stress Relief
•May 17, 2020 35 0 Share Save Vincent Stevenson 1.8K subscribers I discuss Oxidative Stress and how N-Acetylcysteine (NAC) could be a possible COVID-19 treatment or prevention according to a double-blind clinical trial studying the benefits of NAC to reduce…
NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19
NIH Begins Clinical Trial of TOPICS:COVID-19National Institute of Allergy and Infectious DiseasesNational Institutes of HealthPopularPublic Health By National Institutes of Health May 17, 2020 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at…
Hydroxychloroquine used by Korea for Covid-19 while US is divided
Apr 27, 2020, 9:52 PM Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor…
Clinical study on hydroxychloroquine conducted in S. Korea
All Headlines 10:51 April 22, 2020 SEOUL, April 22 (Yonhap) — South Korean researchers have conducted a clinical study on virus preventive treatment using hydroxychloroquine, a controversial drug that has been touted as a possible cure for the novel coronavirus.…
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach -The Lancet
Praveen Tilangi Devashish Desai Adil Khan Manish Soneja Published:May 22, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30430-8 PlumX Metrics 1 We read with interest the Correspondence from Sahaj Rathi and colleagues on hydroxychloroquine prophylaxis for COVID-19 contacts in India.. The authors see the decision by…
Lockdowns reduced infection rate by 81%, study finds
Guardian – view original Ian Sample Lockdowns had a dramatic impact on the spread of coronavirus in Europe with strict controls on people’s movements preventing an estimated 3.1m deaths by the beginning of May, with 470,000 deaths averted in the…
Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea:
J Korean Med Sci. 2020 Apr 6; 35(13): e140. Published online 2020 Mar 31. doi: 10.3346/jkms.2020.35.e140 PMCID: PMC7131899 PMID: 32242347 Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center…
S. Korean researchers prove effectiveness of blood plasma treatment on COVID-19 patients
86,300 views •Apr 7, 2020
We All SHOULD Wear Surgical Masks for SARS-COV-2
Immune System – Peter Berg
Dr Vladimir Zelenko Updates May 28, 2020
President Donald Trump on Hydroxychloroquine
Ignaz Philipp Semmelweis
Ignaz Philipp Semmelweis[A] (German: [ˈɪɡnaːts ˈzɛml̩vaɪs]; Hungarian: Semmelweis Ignác Fülöp; 1 July 1818 – 13 August 1865) was a Hungarian physician and scientist, now known as an early pioneer of antiseptic procedures. Described as the “saviour of mothers”,[2] Semmelweis discovered that…
FDA on Off-Label Use of a Drug
Understanding Unapproved Use of Approved Drugs “Off Label” view original Has your healthcare provider ever talked to you about using an FDA-approved drug for an unapproved use (sometimes called an “off-label” use) to treat your disease or medical condition?…
The Israel Institute for Biological Research (IIBR) Completed Potential Antibody treatment for COVID-19
The Israel Institute for Biological Research (IIBR) said on Tuesday that it completed a “groundbreaking scientific development” toward a potential treatment for COVID-19 based on an antibody that neutralizes SARS-CoV2, the coronavirus that causes the disease. The Israeli Ministry of…
Antibody Test in Israel
Antibody tests, planned to begin this week, said to face significant delay Health Ministry and HMOs don’t know when serological testing will begin to better monitor COVID-19 infection rates — and prepare for a potential second wave By TOI staff…
Dr. Vladimir Zelenko May 21
Monoclonal Antibodies – NIH
Enlisting Monoclonal Antibodies in the Fight Against COVID-19 Posted on May 21st, 2020 by Dr. Francis Collins B38 Antibody and SARS-CoV-2 wtih ACE2 Receptor Caption: Antibody Binding to SARS-CoV-2. Structural illustration of B38 antibody (cyan, green) attached to receptor-binding domain…
